- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by PharmaLogic Development, Inc.
Total 1137 results
-
Ironshore Pharmaceuticals and Development, IncCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Schizoaffective Disorder | First Episode PsychosisUnited Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, India, South Africa, Estonia, Russian Federation, Mexico, Korea, Republic of, Malaysia, Bulgaria, Hungary, Croatia, Serbia, Poland, Romania, Puerto Rico, Slovakia, Chile, Taiwan, Thailand, Australia, Spain, Argentina, Finlan... and more
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultidrug-resistant TuberculosisSouth Africa, Estonia, Philippines, Peru, Lithuania, Latvia, Moldova, Republic of
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, MajorUnited States, France, Poland, Russian Federation, Romania, Ukraine, Germany, Hungary, Slovakia, Serbia, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Bipolar I DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Withdrawn
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaKorea, Republic of, United States, Philippines, Malaysia, Croatia, Serbia, Russian Federation, Ukraine, Romania, Puerto Rico, Colombia, Turkey, Poland, Taiwan, Canada, Latvia, Slovakia, Mexico, Japan
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedChronic Obstructive Pulmonary DiseaseUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSyndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)Germany, United Kingdom, Spain, Sweden, Hungary, Czech Republic, Denmark
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMajor Depressive DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, MajorUnited States, Russian Federation, Hungary, Romania, Ukraine, Canada, Germany
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAcute SchizophreniaUnited States, Philippines, Taiwan, Russian Federation, Croatia, Colombia, Mexico, Slovakia
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Psychiatric DisordersUnited States
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedSchizophreniaBelgium, Bulgaria, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTic Disorder | Tourette's DisorderUnited States, Germany, Spain, Mexico, Romania, Canada, Hungary, Italy, Sweden
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Mental Disorder | Bipolar 1 Disorder | Nervous System DisordersUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBipolar I DisorderUnited States, Argentina
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAlzheimer DiseaseUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAlzheimer DiseaseUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaRussian Federation, Argentina, Croatia, India, Serbia, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Bipolar DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedUlcerative ColitisUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedHeart Failure, CongestiveUnited States, Romania
-
Otsuka Pharmaceutical Development & Commercialization...CompletedUlcerative ColitisUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedCongestive Heart FailureCanada, United States
-
COUR Pharmaceutical Development Company, Inc.RecruitingMyasthenia Gravis | Generalized Myasthenia | AChR Myasthenia Gravis | MuSK MGUnited States
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAutosomal Recessive Polycystic Kidney (ARPKD)United States, United Kingdom, Belgium, Poland, France, Germany, Italy
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Belgium, Canada, Chile, Colombia, Croatia, Hungary, Mexico, Netherlands, Slovakia, Slovenia, Spain, Ireland
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Bulgaria, Denmark, Estonia, Greece, Poland, Portugal, Puerto Rico, United Kingdom, Germany, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...Enrolling by invitationImmunoglobulin A NephropathyUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeSpain, United States, Italy, United Kingdom, Hungary, France, Poland, Australia, Bulgaria, Czechia, South Africa
-
COUR Pharmaceutical Development Company, Inc.Terminated
-
COUR Pharmaceutical Development Company, Inc.Terminated
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPost Traumatic Stress DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Estonia, Germany, Poland, Portugal, Puerto Rico
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBorderline Personality DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Terminated
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTuberculosis, Pulmonary | Extensively Drug-Resistant Tuberculosis | Tuberculosis, Multidrug ResistantKorea, Republic of, China, United States, Egypt, Estonia, Japan, Latvia, Peru, Philippines
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedTuberculosisLatvia, Lithuania
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTuberculosis, Multidrug-ResistantKorea, Republic of, China, Estonia, Latvia, Peru, Philippines
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Australia, Bulgaria, Romania, India, Slovakia, Philippines
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney Disease (ADPKD)United States, Australia, Belgium, Germany, Italy, Poland, Romania, United Kingdom, Argentina, Canada, France, Netherlands, Russian Federation
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity Disorder | Attention Deficit DisorderUnited States